N
Nusirt
Biotechnology company focused on developing products
About Nusirt
NuSirt Biopharma, Inc. is a pioneering biotech company that has developed a unique technology platform integrating natural compounds with pharmaceutical agents. This innovative approach is protected by an extensive intellectual property (IP) portfolio, which includes thirteen issued or allowed patents and several pending globally. The company has successfully validated its technology through multiple clinical studies, demonstrating its potential in treating various metabolic disorders, including Type 2 Diabetes. NuSirt operates in the biopharmaceutical market, primarily serving healthcare providers and patients seeking advanced treatment options. The business model revolves around the development and commercialization of its proprietary technology, generating revenue through licensing agreements, partnerships, and direct sales of its therapeutic solutions.
Source: Dealroom company dataAt a glance
- Founded
- 2007
- Headquarters
- Nashville, United States
- Sector
- Biotech & Life Sciences
Latest news
Press, funding announcements and product moves mentioning Nusirt.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
- TVTennessee Community Ventures
Series B and later2 investors entered at this stage
Hatteras Venture Partners- TPTriStar Health Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Nusirt on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nusirt on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.